Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Pasadena. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Pasadena at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD)
Sponsor: Kodiak Sciences Inc
Check if you qualify for this macular degeneration clinical trial in Pasadena, CA
If you're searching for macular degeneration treatment options in Pasadena, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pasadena research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.